Phosphoinositide hydrolysis mediated by histamine H1-receptors in rat brain cortex.

Article Details

Citation

Claro E, Arbones L, Garcia A, Picatoste F

Phosphoinositide hydrolysis mediated by histamine H1-receptors in rat brain cortex.

Eur J Pharmacol. 1986 Apr 16;123(2):187-96.

PubMed ID
3011460 [ View in PubMed
]
Abstract

Histamine stimulated the accumulation of [3H]inositol 1-phosphate in the presence of lithium in [3H]inositol-prelabelled slices from rat brain cortex in a concentration-dependent manner, with an EC50 value of 94.7 microM. High concentrations of antagonists of histamine H2 receptors, muscarinic receptors, alpha 1-adrenoceptors and serotonin receptors did not inhibit the effect. The histamine H1-receptor antagonists mepyramine, triprolidine, promethazine, d-chlorpheniramine and the tricyclic antidepressant doxepin inhibited the response with Ki values corresponding to an interaction with histamine H1-receptors. The EC50 for the response was about three times lower than the Ki value (approximately 300 microM) for the inhibition by histamine of [3H]mepyramine binding to membranes from rat brain cortex. Partial inactivation of H1-receptors with the alkylating antagonist phenoxybenzamine resulted in similar reductions in [3H]mepyramine binding sites and in the maximal histamine-induced [3H]inositol 1-phosphate accumulation, without affecting the KD for the radioligand or the EC50 for the response. The apparent dissociation constant for histamine calculated from these experiments (KA = 92.2 microM) was not different from the EC50 value. The present results indicate that histamine-stimulated phosphoinositide hydrolysis in rat brain cortex is mediated by H1-receptors and that no receptor reserve is present.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
DoxepinHistamine H1 receptorProteinHumans
Yes
Antagonist
Details
PromethazineHistamine H1 receptorProteinHumans
Yes
Antagonist
Details
TriprolidineHistamine H1 receptorProteinHumans
Yes
Antagonist
Details